$177M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | VSTM Verastem Inc | 3.3M | +1.4% | $13M | 7.2% |
| 2 | EOLS Evolus Inc | 1.6M | −9.6% | $11M | 6.2% |
| 3 | TENX Tenax Therapeutics Inc | 660,000 | −32.3% | $10M | 5.4% |
| 4 | NKTR Nektar Therapeutics | 120,654 | +41.9% | $8M | 4.8% |
| 5 | ADMA Adma Biologics Inc | 740,000 | +0.0% | $6M | 3.5% |
| 6 | CAMP Camp4 Therapeutics Corp | 1.4M | +0.0% | $6M | 3.4% |
| 7 | ELOX Eloxx Pharmaceuticals Inc | 397,160 | — | $6M | 3.1% |
| 8 | KZIA Kazia Therapeutics Ltd | 345,179 | +0.0% | $5M | 2.7% |
| 9 | INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc | 100,000 | — | $4M | 2.3% |
| 10 | CRBP Corbus Pharmaceuticals Hldgs | 425,000 | +10.8% | $4M | 2.2% |
| 11 | MSLE Satellos Bioscience Inc | 491,624 | +391.6% | $4M | 2.1% |
| 12 | ZVRA Zevra Therapeutics Inc | 258,701 | −46.1% | $4M | 2.1% |
| 13 | ABEO Abeona Therapeutics Inc | 557,284 | −25.4% | $3M | 1.9% |
| 14 | EDSA Edesa Biotech Inc | 456,439 | +1421.5% | $3M | 1.8% |
| 15 | CABA Cabaletta Bio Inc | 917,100 | +1734.2% | $3M | 1.6% |
| 16 | ANTX An2 Therapeutics Inc | 551,692 | −22.7% | $3M | 1.5% |
| 17 | XLO Xilio Therapeutics Inc | 225,994 | +252.2% | $2M | 1.2% |
| 18 | ACET Adicet Bio Inc | 245,518 | +10.6% | $2M | 1.2% |
| 19 | TELA Tela Bio Inc | 2.7M | +1.7% | $2M | 1.1% |
| 20 | AYTU Aytu Biopharma Inc | 912,921 | +15.2% | $2M | 1.1% |
| 21 | CRIS Curis Inc | 3.3M | −11.1% | $2M | 1.0% |
| 22 | SPRB Spruce Biosciences Inc | 28,795 | — | $2M | 0.9% |
| 23 | OKYO Okyo Pharma Ltd | 862,996 | +1.5% | $1M | 0.7% |
| 24 | KTTA Pasithea Therapeutics Corp | 2.2M | +164.8% | $1M | 0.6% |
| 25 | SLGL Sol-Gel Technologies Ltd | 14,469 | −47.9% | $1M | 0.6% |
| 26 | LUNG Pulmonx Corp | 815,436 | +6.1% | $1M | 0.6% |
| 27 | XFOR X4 Pharmaceuticals Inc | 224,989 | −32.9% | $1M | 0.6% |
| 28 | INAB In8Bio Inc | 695,287 | +4.8% | $980,355 | 0.6% |
| 29 | MLTX Moonlake Immunotherapeutics | 50,000 | — | $973,500 | 0.5% |
| 30 | QNRX Quoin Pharmaceuticals Ltd | 199,486 | +273.2% | $965,512 | 0.5% |
| 31 | MXCT Maxcyte Inc | 751,606 | −25.2% | $924,475 | 0.5% |
| 32 | PHAT Phathom Pharmaceuticals Inc | 85,010 | +70.0% | $922,358 | 0.5% |
| 33 | AZTR Azitra Inc | 5.3M | — | $886,903 | 0.5% |
| 34 | CNTB Connect Biopharma Hldgs Ltd | 364,254 | +17.5% | $866,925 | 0.5% |
| 35 | CYBIN INC Cybin Inc | 129,280 | −3.6% | $854,541 | 0.5% |
| 36 | RARE Ultragenyx Pharmaceutical In | 25,000 | — | $834,750 | 0.5% |
| 37 | IKT Inhibikase Therapeutics Inc | 396,179 | −58.6% | $804,243 | 0.5% |
| 38 | ZNTL Zentalis Pharmaceuticals Inc | 161,583 | −40.0% | $783,678 | 0.4% |
| 39 | CTMX Cytomx Therapeutics Inc. | 205,000 | +2.5% | $768,750 | 0.4% |
| 40 | NVCT Nuvectis Pharma Inc | 40,000 | — | $735,600 | 0.4% |
| 41 | CBIO Crescent Biopharma Inc. | 40,000 | −52.9% | $720,000 | 0.4% |
| 42 | PMVP Pmv Pharmaceuticals Inc | 536,086 | −24.3% | $718,355 | 0.4% |
| 43 | ORKA Oruka Therapeutics Inc | 7,500 | — | $713,775 | 0.4% |
| 44 | RADX Radiopharm Theranostics Ltd | 51.0M | +0.0% | $670,500 | 0.4% |
| 45 | OKUR Onkure Therapeutics Inc | 130,684 | −1.4% | $595,919 | 0.3% |
| 46 | NGEN Nervgen Pharma Corp | 271,678 | — | $559,657 | 0.3% |
| 47 | CALC Calcimedica Inc | 622,432 | — | $544,939 | 0.3% |
| 48 | ARVN Arvinas Inc | 60,000 | +118.2% | $498,600 | 0.3% |
| 49 | BIOA Bioage Labs Inc | 20,000 | −60.0% | $490,200 | 0.3% |
| 50 | IRD Opus Genetics Inc | 100,718 | +46.6% | $413,951 | 0.2% |